X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (90) 90
index medicus (77) 77
oncology (76) 76
male (53) 53
cancer (46) 46
female (40) 40
aged (37) 37
middle aged (36) 36
chemotherapy (30) 30
urology & nephrology (29) 29
bladder cancer (28) 28
immunotherapy (28) 28
treatment outcome (27) 27
survival (26) 26
antineoplastic agents - therapeutic use (24) 24
therapy (22) 22
neoplasm staging (21) 21
carcinoma (20) 20
metastasis (20) 20
urology (20) 20
aged, 80 and over (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
article (19) 19
adult (18) 18
urothelial carcinoma (18) 18
prognosis (17) 17
trial (17) 17
urinary bladder neoplasms - drug therapy (17) 17
cisplatin (16) 16
renal cell carcinoma (16) 16
kidney cancer (15) 15
kidney neoplasms - drug therapy (15) 15
neoadjuvant chemotherapy (15) 15
carcinoma, renal cell (14) 14
carcinoma, renal cell - drug therapy (14) 14
care and treatment (14) 14
urinary bladder neoplasms - pathology (14) 14
antibodies, monoclonal - therapeutic use (13) 13
bladder-cancer (13) 13
carcinoma, transitional cell - drug therapy (13) 13
everolimus (13) 13
research (13) 13
transitional-cell carcinoma (13) 13
clinical trials (12) 12
nivolumab (12) 12
pazopanib (12) 12
sunitinib (12) 12
tumors (12) 12
carcinoma, renal cell - mortality (11) 11
drug therapy (11) 11
kidney neoplasms - mortality (11) 11
kidney neoplasms - pathology (11) 11
open-label (11) 11
abridged index medicus (10) 10
analysis (10) 10
clear cell-type renal cell carcinoma (10) 10
interferon-alpha (10) 10
neoadjuvant therapy (10) 10
patients (10) 10
radical cystectomy (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
cancer therapies (9) 9
carcinoma, transitional cell - pathology (9) 9
combined modality therapy (9) 9
disease-free survival (9) 9
gemcitabine (9) 9
metastases (9) 9
neoplasm invasiveness (9) 9
neoplasm metastasis (9) 9
retrospective studies (9) 9
urinary bladder neoplasms - therapy (9) 9
antibodies, monoclonal - adverse effects (8) 8
antineoplastic agents - adverse effects (8) 8
carcinoma, renal cell - pathology (8) 8
clinical trials as topic (8) 8
disease progression (8) 8
dose-response relationship, drug (8) 8
expression (8) 8
kidney neoplasms - surgery (8) 8
melanoma (8) 8
molecular targeted therapy (8) 8
safety (8) 8
urologic neoplasms - pathology (8) 8
adjuvant chemotherapy (7) 7
bevacizumab (7) 7
drug administration schedule (7) 7
follow-up studies (7) 7
medical prognosis (7) 7
nephrectomy (7) 7
phase-iii trial (7) 7
prognostic-factors (7) 7
prospective studies (7) 7
prostate cancer (7) 7
sorafenib (7) 7
survival rate (7) 7
toxicity (7) 7
urologic neoplasms - drug therapy (7) 7
antineoplastic agents (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
carcinoma, renal cell - immunology (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 594 - 594
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 4567 - 4567
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e13025 - e13025
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 389 - 389
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 451 - 451
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 6506 - 6506
Journal Article
Current Urology Reports, ISSN 1527-2737, 12/2018, Volume 19, Issue 12, pp. 1 - 10
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 674 - 674
Journal Article
Current Opinion in Urology, ISSN 0963-0643, 07/2019, Volume 29, Issue 4, pp. 350 - 356
PURPOSE OF REVIEWThe purpose of this review is to examine and evaluate similarities and differences in bladder cancer expression subtypes and to understand the... 
LUMINAL SUBTYPES | expression profiling | UROTHELIAL CARCINOMA | DOXORUBICIN | VINBLASTINE | neoadjuvant chemotherapy | EVOLUTION | muscle-invasive bladder cancer | molecular subtype | DOSE-DENSE METHOTREXATE | GENE-EXPRESSION | UROLOGY & NEPHROLOGY | chemoresponse | CYSTECTOMY | cisplatin | Genetic aspects | Research | Gene expression | Bladder cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. TPS4587 - TPS4587
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1803 - 1813
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 3069 - 3069
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.